In human clinical trials, the product label is the source of that power – it's the voice of the product and it needs to speak clearly throughout a highly complex process
New Zealand gives clearance for base editing therapy trial in humans
Risk-based quality management (RBQM) is nothing new – it's been around in some form or another for a long time – but over that time
A new era of smart therapeutics with first-ever computationally designed antibody
A second COVID-19 booster for over 50’s has been approved by the FDA
Science can create miracles. But with the best will in the world, it can’t hold your hand. It can create life-changing treatments, but it can’t advise what’s best in your situation.
We’re all conscious of doing our bit for charity to help improve the well-being of others. Usually, our first thought is to contribute money to a cause. We don’t tend to think of supply chains and logistics providers as having a natural philanthropic...
Scientists have posed serious questions about a new drug which claims to improve cognition in Alzheimer’s patients. For more, click here
A recent US court decision effecting research exclusivity which could widely impede research and development into the treatment of rare diseases has prompted the FDA to lobby Congress
Напишите нам на почту info@corex-depot.com или свяжитесь с нами через форму обратной связи.